Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Don't jump to rash conclusions.

× No keyword cloud information.

3 in total

1. Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors.

Authors: Dejan Juric; Rodrigo Dienstmann; Andres Cervantes; Manuel Hidalgo; Wells Messersmith; George R Blumenschein; Josep Tabernero; Desamparados Roda; Antonio Calles; Antonio Jimeno; Xiaodong Wang; Sandra Sanabria Bohórquez; Cecilia Leddy; Catherine Littman; Amy V Kapp; David S Shames; Elicia Penuel; Lukas C Amler; Andrea Pirzkall; José Baselga
Journal: Clin Cancer Res Date: 2015-06-01 Impact factor: 12.531

2. A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.

Authors: Lucely Cetina; Tania Crombet; Roberto Jiménez-Lima; Sergio Zapata; Mayra Ramos; Sandra Avila; Jaime Coronel; Eduardo Charco; Rafael Bojalil; Horacio Astudillo; Blanca Bazán; Alfonso Dueñas-González
Journal: Cancer Biol Ther Date: 2015 Impact factor: 4.742

3. Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities.

Authors: Arlhee Diaz-Miqueli; Giselle Saurez Martinez
Journal: Onco Targets Ther Date: 2013-07-24 Impact factor: 4.147

3 in total